Mark Cobbold, Ph.D., M.B.Ch.B.
Cancer Center, Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
|MBCHB University of Edinburgh 1995|
|PhD University of Birmingham-UK 2006|
In patients with cancer, this immunity is often lost and therefore new approaches may be needed. We are developing therapeutics that mobilize existing potent immune responses to instead tackle cancer. These immune-based therapies make cancerous cells appear virally infected in the hope that our own anti-viral immunity could step in to fill the void.